Intestinal mucosal barrier repair and immune regulation with an AI-developed gut-restricted PHD inhibitor
Yanyun Fu(China Executive Leadership Academy Pudong), Alex Zhavoronkov(Hong Kong Science and Technology Parks Corporation), Frank W. Pun(Hong Kong Science and Technology Parks Corporation), Chenxi Xu(Chinese Academy of Sciences), Yaya Fan(Huazhong Agricultural University), David Gennert(Insilicos (United States)), Chunlei Feng(Insilicos (United States)), Fadi E. Pulous(Harvard University), Petrina Kamya, Alexander Aliper(Insilico Medicine (United States)), Liang Xing, Man Zhang(Xinjiang Agricultural University), Shan Chen(Insilico Biotechnology (Germany)), Ling Wang(Insilicos (United States)), Rui Wang(Sun Yat-sen University), Ziqi Yan(University of Arizona), Xiaoyu Ding(Insilicos (United States)), Feng Ren(Unknown), Jianyu Xu(Insilicos (United States)), Xiaoxia Lin(Sun Yat-sen University), Yushu Yin(Insilicos (United States)), Xiao Ding(Harbin Institute of Technology), Taotao Li(Insilicos (United States))
Cited by 45
Related Papers
Accurate Multiplex Polony Sequencing of an Evolved Bacterial Genome
|Science|2005|1.4k
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth
|JAMA|2015|416
Deep biomarkers of human aging: Application of deep neural networks to biomarker development
|Aging|2016|377
AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor
|Chemical Science|2023|322
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311